Adenoviridae Infections  >>  Nimenrix (MenACWY-TT)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Nimenrix (MenACWY-TT) / Pfizer
NCT02548078 / 2014-004714-28: A Study to Evaluate the Safety and Immunogenicity of a Candidate Ebola Vaccine in Children

Completed
2
600
RoW
GlaxoSmithKline (GSK) Biologicals' investigational recombinant chimpanzee adenovirus Type 3-vectored Ebola Zaire vaccine (ChAd3-EBO-Z) (GSK3390107A), Nimenrix powder and solvent for solution for injection in pre-filled syringe; Meningococcal group A, C, W-135 and Y conjugate vaccine
GlaxoSmithKline
Virus Diseases
05/17
05/17

Download Options